IOBT Stock Summary and Trading Ideas (Io Biotech | NASDAQ:IOBT)

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Io Biotech trades on the NASDAQ stock market under the symbol IOBT.

As of December 19, 2025, IOBT stock price climbed to $0.66 with 505,367 million shares trading.

IOBT has a beta of 0.37, meaning it tends to be less sensitive to market movements. IOBT has a correlation of 0.00 to the broad based SPY ETF.

IOBT has a market cap of $47.81 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, IOBT traded as high as $3.30 and as low as $.32.

IOBT has underperformed the market in the last year with a price return of -13.2% while the SPY ETF gained +17.3%. IOBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -59.0% and -2.0%, respectively, while the SPY returned +3.3% and -0.6%, respectively.

IOBT support price is $.58 and resistance is $.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IOBT shares will trade within this expected range on the day.